Global Human Milk Oligosaccharides (HMO) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 98

Published Date: 10 Apr 2024

Category: Food & Beverages

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at US$ 593 million in 2023 and is forecast to a readjusted size of USD 2644 million by 2030 with a CAGR of 24.0% during review period.

The core manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, DSM (Glycom) and Chr. Hansen (Jennewein). The top three companies hold about 83% of the market. North America is the world's largest Human Milk Oligosaccharides (HMO) market with a market share of about 54%, followed by Europe and Asia Pacific with a market share of 31% and 13%, respectively. In terms of product type, 2'-FL & 3-FL is the largest segments, accounting for approximately 96% of the market share. In terms of application, Infant Formula is the largest downstream sector, accounting for about 96% of the market share.

This report is a detailed and comprehensive analysis for global Human Milk Oligosaccharides (HMO) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Human Milk Oligosaccharides (HMO) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Human Milk Oligosaccharides (HMO) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Human Milk Oligosaccharides (HMO) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Human Milk Oligosaccharides (HMO) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Milk Oligosaccharides (HMO)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.

Market segment by Application
Infant Formula
Others

Market segment by players, this report covers
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Milk Oligosaccharides (HMO), with revenue, gross margin, and global market share of Human Milk Oligosaccharides (HMO) from 2019 to 2024.
Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Human Milk Oligosaccharides (HMO) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides (HMO).
Chapter 13, to describe Human Milk Oligosaccharides (HMO) research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Human Milk Oligosaccharides (HMO) by Type
        1.3.1 Overview: Global Human Milk Oligosaccharides (HMO) Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type in 2023
        1.3.3 2'-FL & 3-FL
        1.3.4 LNT & LNnT, etc.
    1.4 Global Human Milk Oligosaccharides (HMO) Market by Application
        1.4.1 Overview: Global Human Milk Oligosaccharides (HMO) Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Infant Formula
        1.4.3 Others
    1.5 Global Human Milk Oligosaccharides (HMO) Market Size & Forecast
    1.6 Global Human Milk Oligosaccharides (HMO) Market Size and Forecast by Region
        1.6.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Human Milk Oligosaccharides (HMO) Market Size by Region, (2019-2030)
        1.6.3 North America Human Milk Oligosaccharides (HMO) Market Size and Prospect (2019-2030)
        1.6.4 Europe Human Milk Oligosaccharides (HMO) Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size and Prospect (2019-2030)
        1.6.6 South America Human Milk Oligosaccharides (HMO) Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Human Milk Oligosaccharides (HMO) Product and Solutions
        2.1.4 Abbott Human Milk Oligosaccharides (HMO) Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Abbott Recent Developments and Future Plans
    2.2 Inbiose
        2.2.1 Inbiose Details
        2.2.2 Inbiose Major Business
        2.2.3 Inbiose Human Milk Oligosaccharides (HMO) Product and Solutions
        2.2.4 Inbiose Human Milk Oligosaccharides (HMO) Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Inbiose Recent Developments and Future Plans
    2.3 Glycom
        2.3.1 Glycom Details
        2.3.2 Glycom Major Business
        2.3.3 Glycom Human Milk Oligosaccharides (HMO) Product and Solutions
        2.3.4 Glycom Human Milk Oligosaccharides (HMO) Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Glycom Recent Developments and Future Plans
    2.4 Chr. Hansen (Jennewein)
        2.4.1 Chr. Hansen (Jennewein) Details
        2.4.2 Chr. Hansen (Jennewein) Major Business
        2.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Solutions
        2.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Chr. Hansen (Jennewein) Recent Developments and Future Plans
    2.5 Elicityl SA
        2.5.1 Elicityl SA Details
        2.5.2 Elicityl SA Major Business
        2.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Product and Solutions
        2.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Elicityl SA Recent Developments and Future Plans
    2.6 ZuChem
        2.6.1 ZuChem Details
        2.6.2 ZuChem Major Business
        2.6.3 ZuChem Human Milk Oligosaccharides (HMO) Product and Solutions
        2.6.4 ZuChem Human Milk Oligosaccharides (HMO) Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 ZuChem Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Human Milk Oligosaccharides (HMO) Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Human Milk Oligosaccharides (HMO) by Company Revenue
        3.2.2 Top 3 Human Milk Oligosaccharides (HMO) Players Market Share in 2023
        3.2.3 Top 6 Human Milk Oligosaccharides (HMO) Players Market Share in 2023
    3.3 Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
        3.3.1 Human Milk Oligosaccharides (HMO) Market: Region Footprint
        3.3.2 Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
        3.3.3 Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Human Milk Oligosaccharides (HMO) Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2024)
    5.2 Global Human Milk Oligosaccharides (HMO) Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
    6.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2030)
    6.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
        6.3.1 North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        6.3.2 United States Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        6.3.3 Canada Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        6.3.4 Mexico Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
    7.2 Europe Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
    7.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
        7.3.1 Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        7.3.2 Germany Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        7.3.3 France Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        7.3.5 Russia Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        7.3.6 Italy Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region
        8.3.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
        8.3.2 China Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        8.3.3 Japan Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        8.3.4 South Korea Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        8.3.5 India Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        8.3.7 Australia Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
    9.2 South America Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
    9.3 South America Human Milk Oligosaccharides (HMO) Market Size by Country
        9.3.1 South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        9.3.2 Brazil Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        9.3.3 Argentina Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country
        10.3.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
        10.3.2 Turkey Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)
        10.3.4 UAE Human Milk Oligosaccharides (HMO) Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Human Milk Oligosaccharides (HMO) Market Drivers
    11.2 Human Milk Oligosaccharides (HMO) Market Restraints
    11.3 Human Milk Oligosaccharides (HMO) Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Human Milk Oligosaccharides (HMO) Industry Chain
    12.2 Human Milk Oligosaccharides (HMO) Upstream Analysis
    12.3 Human Milk Oligosaccharides (HMO) Midstream Analysis
    12.4 Human Milk Oligosaccharides (HMO) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Abbott Company Information, Head Office, and Major Competitors
 Table 6. Abbott Major Business
 Table 7. Abbott Human Milk Oligosaccharides (HMO) Product and Solutions
 Table 8. Abbott Human Milk Oligosaccharides (HMO) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Abbott Recent Developments and Future Plans
 Table 10. Inbiose Company Information, Head Office, and Major Competitors
 Table 11. Inbiose Major Business
 Table 12. Inbiose Human Milk Oligosaccharides (HMO) Product and Solutions
 Table 13. Inbiose Human Milk Oligosaccharides (HMO) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Inbiose Recent Developments and Future Plans
 Table 15. Glycom Company Information, Head Office, and Major Competitors
 Table 16. Glycom Major Business
 Table 17. Glycom Human Milk Oligosaccharides (HMO) Product and Solutions
 Table 18. Glycom Human Milk Oligosaccharides (HMO) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Chr. Hansen (Jennewein) Company Information, Head Office, and Major Competitors
 Table 20. Chr. Hansen (Jennewein) Major Business
 Table 21. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Solutions
 Table 22. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Chr. Hansen (Jennewein) Recent Developments and Future Plans
 Table 24. Elicityl SA Company Information, Head Office, and Major Competitors
 Table 25. Elicityl SA Major Business
 Table 26. Elicityl SA Human Milk Oligosaccharides (HMO) Product and Solutions
 Table 27. Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Elicityl SA Recent Developments and Future Plans
 Table 29. ZuChem Company Information, Head Office, and Major Competitors
 Table 30. ZuChem Major Business
 Table 31. ZuChem Human Milk Oligosaccharides (HMO) Product and Solutions
 Table 32. ZuChem Human Milk Oligosaccharides (HMO) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. ZuChem Recent Developments and Future Plans
 Table 34. Global Human Milk Oligosaccharides (HMO) Revenue (USD Million) by Players (2019-2024)
 Table 35. Global Human Milk Oligosaccharides (HMO) Revenue Share by Players (2019-2024)
 Table 36. Breakdown of Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 37. Market Position of Players in Human Milk Oligosaccharides (HMO), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 38. Head Office of Key Human Milk Oligosaccharides (HMO) Players
 Table 39. Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
 Table 40. Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
 Table 41. Human Milk Oligosaccharides (HMO) New Market Entrants and Barriers to Market Entry
 Table 42. Human Milk Oligosaccharides (HMO) Mergers, Acquisition, Agreements, and Collaborations
 Table 43. Global Human Milk Oligosaccharides (HMO) Consumption Value (USD Million) by Type (2019-2024)
 Table 44. Global Human Milk Oligosaccharides (HMO) Consumption Value Share by Type (2019-2024)
 Table 45. Global Human Milk Oligosaccharides (HMO) Consumption Value Forecast by Type (2025-2030)
 Table 46. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024)
 Table 47. Global Human Milk Oligosaccharides (HMO) Consumption Value Forecast by Application (2025-2030)
 Table 48. North America Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
 Table 49. North America Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
 Table 50. North America Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
 Table 51. North America Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
 Table 52. North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
 Table 53. North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
 Table 54. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
 Table 55. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
 Table 56. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
 Table 57. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
 Table 58. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
 Table 59. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
 Table 60. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
 Table 61. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
 Table 62. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
 Table 63. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
 Table 64. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
 Table 65. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
 Table 66. South America Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. South America Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. South America Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
 Table 69. South America Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
 Table 70. South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
 Table 71. South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
 Table 72. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
 Table 73. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
 Table 74. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
 Table 75. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
 Table 76. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
 Table 77. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
 Table 78. Global Key Players of Human Milk Oligosaccharides (HMO) Upstream (Raw Materials)
 Table 79. Global Human Milk Oligosaccharides (HMO) Typical Customers


List of Figures
 Figure 1. Human Milk Oligosaccharides (HMO) Picture
 Figure 2. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type in 2023
 Figure 4. 2'-FL & 3-FL
 Figure 5. LNT & LNnT, etc.
 Figure 6. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application in 2023
 Figure 8. Infant Formula Picture
 Figure 9. Others Picture
 Figure 10. Global Human Milk Oligosaccharides (HMO) Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global Human Milk Oligosaccharides (HMO) Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global Market Human Milk Oligosaccharides (HMO) Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 13. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
 Figure 14. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region in 2023
 Figure 15. North America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 16. Europe Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 17. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 18. South America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 19. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Human Milk Oligosaccharides (HMO) Revenue Share by Players in 2023
 Figure 22. Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 23. Market Share of Human Milk Oligosaccharides (HMO) by Player Revenue in 2023
 Figure 24. Top 3 Human Milk Oligosaccharides (HMO) Players Market Share in 2023
 Figure 25. Top 6 Human Milk Oligosaccharides (HMO) Players Market Share in 2023
 Figure 26. Global Human Milk Oligosaccharides (HMO) Consumption Value Share by Type (2019-2024)
 Figure 27. Global Human Milk Oligosaccharides (HMO) Market Share Forecast by Type (2025-2030)
 Figure 28. Global Human Milk Oligosaccharides (HMO) Consumption Value Share by Application (2019-2024)
 Figure 29. Global Human Milk Oligosaccharides (HMO) Market Share Forecast by Application (2025-2030)
 Figure 30. North America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
 Figure 31. North America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
 Figure 32. North America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
 Figure 33. United States Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 34. Canada Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 35. Mexico Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 36. Europe Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
 Figure 37. Europe Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
 Figure 38. Europe Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
 Figure 39. Germany Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 40. France Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 41. United Kingdom Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 42. Russia Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 43. Italy Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 44. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
 Figure 45. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
 Figure 46. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
 Figure 47. China Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 48. Japan Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 49. South Korea Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 50. India Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 51. Southeast Asia Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 52. Australia Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 53. South America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
 Figure 54. South America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
 Figure 55. South America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
 Figure 56. Brazil Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 57. Argentina Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 58. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
 Figure 59. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
 Figure 60. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
 Figure 61. Turkey Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 62. Saudi Arabia Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 63. UAE Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
 Figure 64. Human Milk Oligosaccharides (HMO) Market Drivers
 Figure 65. Human Milk Oligosaccharides (HMO) Market Restraints
 Figure 66. Human Milk Oligosaccharides (HMO) Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Human Milk Oligosaccharides (HMO) Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Related Reports

Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Food & Beverages

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2023-2029

Global Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2023-2029

date 12 Jan 2023

date Food & Beverages

The global Human Milk Oligosaccharides (HMO) market size is expected to reach $ 1197.9 million by 2029, rising at a market growth of 13.9% CAGR during the forecast period (2023-2029).

Global Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Food & Beverages

According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at USD 481.2 million in 2023 and is forecast to a readjusted size of USD 1197.9 million by 2030 with a CAGR of 13.9% during review period.

Global Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2024-2030

Global Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2024-2030

date 10 Apr 2024

date Food & Beverages

The global Human Milk Oligosaccharides (HMO) market size is expected to reach $ 2644 million by 2030, rising at a market growth of 24.0% CAGR during the forecast period (2024-2030).

Product Tags

Human Milk Oligosaccharides (HMO)

Sialylated Human Milk Oligosaccharides (HMO)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>